Eli Lilly Work in process increased by 11.8% to $7.27B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 80.3%, from $4.04B to $7.27B.
inv_work_in_progress| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|
| Value | $3.25B | $3.61B | $3.71B | $4.04B | $3.98B | $5.30B | $6.51B | $7.27B |
| QoQ Change | — | +11.2% | +2.6% | +8.9% | -1.4% | +33.1% | +22.9% | +11.8% |
| YoY Change | — | — | — | — | +22.5% | +46.6% | +75.6% | +80.3% |
| % of Inventories | 56.3% | 60.1% | 58.0% | 54.6% | 52.4% | 57.1% | 59.1% | 59.5% |
| Share Change | — | +3.9pp | -2.2pp | -3.3pp | -2.2pp | +4.6pp | +2.0pp | +0.4pp |
We use cookies for analytics. See our Privacy and Cookie Policy.